The EPERZAN brand, founded in 2007 (United Kingdom), from 1722 sister brands and 17479 competing brands. The EPERZAN brand is owned by GSK PLC, a company listed in London. The ISIN, the company's International Securities Identification Number, is GB00BN7SWP63. EPERZAN belongs to the Drug Manufacturers business sector.
